Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2008
12/23/2008US7468350 Glue composition for lung volume reduction
12/23/2008US7468278 having pesticidal activity against insect pests, including Coleoptera
12/23/2008US7468273 Canine GHRH gene, polypeptides and methods of use
12/23/2008US7468268 Nucleic acid molecules encoding osteoclastogenesis inhibitory factor proteins
12/23/2008US7468262 Polynucleotides encoding useful polypeptides in corynebacterium glutamicum ssp. lactofermentum
12/23/2008US7468259 Influenza vaccine
12/23/2008US7468257 Protein S functional assay
12/23/2008US7468253 Identifying modulators of chemoattractant receptor using reversed-activation of migration (RAM) high throughput assay
12/23/2008US7468190 Genetic engineering; gene mutant ; reduced virulence of rodent bone marrow macrophages
12/23/2008US7468185 Vaccine for periodontal disease
12/23/2008US7468184 Therapeutic agent for cachexia
12/23/2008US7468183 using an isolated human antibody directed towards at least one oxidized fragment of apolipoprotein B; preparation of the antibody using a fragment library
12/23/2008CA2580848C Technique for extracorporeal treatment of blood
12/23/2008CA2364499C Means and methods for fibroblast-like or macrophage-like cell transduction
12/23/2008CA2267665C Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor
12/23/2008CA2182889C Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
12/23/2008CA2105300C Process for the development of binding mini-proteins
12/18/2008WO2008154547A2 Spider silk dragline polynucleotides, polypeptides and methods of use thereof
12/18/2008WO2008154516A2 Btnl2 fusion protein for t-cell activity modulation
12/18/2008WO2008154456A2 Methods and compositions relating to viral fusion proteins
12/18/2008WO2008154351A1 Rtef-1 variants and the use thereof for inhibition of angiogenesis
12/18/2008WO2008154226A1 Natriuretic fusion proteins
12/18/2008WO2008154101A1 Psm peptides as vaccine targets against methicillin-resistant staphylococcus aureus
12/18/2008WO2008153970A1 Selective cell therapy for the treatment of renal failure
12/18/2008WO2008153963A1 Structure of compstatin-c3 complex and use for rational drug design
12/18/2008WO2008153945A2 Nutraceutical co-crystal compositions
12/18/2008WO2008153935A2 Methods for improving protein properties
12/18/2008WO2008153925A2 Methods for improving multiple protein properties
12/18/2008WO2008153745A2 Compositions and methods for producing bioactive fusion proteins
12/18/2008WO2008153705A2 Methods of treating, diagnosing and detecting fgf21-associated disorders
12/18/2008WO2008153433A1 Monoclonal antibodies for detection of mullerian inhibiting substance and uses thereof
12/18/2008WO2008153429A2 A protease from staphylococcus aureus, particularly spia or spib, peptides it recognises and their use
12/18/2008WO2008153299A1 Method for rejuvenating isolated pancreatic islets for transplantation
12/18/2008WO2008153236A1 An attenuated influenza virus and a live vaccine comprising the same
12/18/2008WO2008152655A1 Anthrax fusion proteins, compositions and uses thereof
12/18/2008WO2008152654A1 Anthrax fusion proteins, compositions and uses thereof
12/18/2008WO2008152652A2 A dengue envelope domain iii-based tetravalent protein vaccine
12/18/2008WO2008152528A2 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
12/18/2008WO2008152527A2 Cell-proliferation inhibiting vpg proteins, fragments or analogs thereof and their applications.
12/18/2008WO2008152447A2 Staphylococcus aureus specific anti-infectives
12/18/2008WO2008152405A2 Protein complexes comprising bh3 peptides and voltage dependent anion channel (vdac) peptides as well as uses thereof for the treatment of proliferative diseases
12/18/2008WO2008152403A1 Glucagon analogues
12/18/2008WO2008152379A1 Labeled single-strand dna-binding protein and its use in a biosensor for detection and visualisation of single-stranded dna
12/18/2008WO2008152262A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system
12/18/2008WO2008152252A2 Rumc peptides with antimicrobial activity
12/18/2008WO2008152140A2 Recombinant transferrin mutants
12/18/2008WO2008151847A1 Autoantibody binding peptides and their use for the treatment of vascular diseases
12/18/2008WO2008151833A2 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds
12/18/2008WO2008151512A1 Site-specific pegylated linear salmon calcitonin derivatives
12/18/2008WO2008151434A1 Small cationic antimicrobial peptides
12/18/2008WO2008151428A1 Novel compositions for modulating mrna translation
12/18/2008WO2008151405A1 Expression of fusion proteins containing a single chain antibody fragment linked to elastin-like repeating units in transgenic plants
12/18/2008WO2008151390A1 Differentiation of human embryonic stem cells
12/18/2008WO2008131315A3 Identification and method for using the pre-ligand assembly domain of the il-17 receptor
12/18/2008WO2008128973A3 Solutions of mannoproteins and their use
12/18/2008WO2008120263A3 Prokineticins receptors antagonists, derivatives and uses thereof
12/18/2008WO2008118691A3 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
12/18/2008WO2008117069A9 Cellulose binding domains and uses thereof
12/18/2008WO2008109833A3 Polynucleotides and polypeptides identified by iviat screening and methods of use
12/18/2008WO2008101017A3 Glucagon/glp-1 receptor co-agonists
12/18/2008WO2008098216A3 Compositions and methods to prevent cancer with cupredoxins
12/18/2008WO2008080112A3 New fusion molecule based on novel taa variant
12/18/2008WO2008077070A3 Crystal structures of hiv-1 protease inhibitors bound to hiv-1 protease
12/18/2008WO2008076490A3 Histophilus somni antigens, compositions and methods of use
12/18/2008WO2008073877B1 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
12/18/2008WO2008030973A3 Methods and compositions for the detection of protein folding disorders
12/18/2008WO2008011192A3 Whole blood-derived coagulum device for treating bone defects
12/18/2008WO2007141650A3 Compositions and methods for diagnosing hiv-2 infection
12/18/2008WO2007098716A8 Compounds analogous to growth hormone peptide secretagogues and preparations containing them
12/18/2008WO2007096859A9 Protection of the retina against laser injury by adnf peptides such as nap and sal
12/18/2008WO2007089601A9 Nogo receptor antagonists
12/18/2008WO2006102170A3 Recombinant mhc molecules useful for manipulation of antigen-specific t cells
12/18/2008US20080313774 Modification of lignin biosynthesis
12/18/2008US20080313772 The Rice Bentazon and Sulfonylurea Herbicide Resistant Gene Cyp81a6
12/18/2008US20080313754 Dominant negative alleles of human mismatch repair genes introduced into cells and transgenic animals; prepared more efficiently than by relying on the natural rate of mutation
12/18/2008US20080313749 Binding Compounds, Immunogenic Compounds and Peptidomimetics
12/18/2008US20080312426 Chicken leukemia inhibitory factor (LIF) and GNNE thereof
12/18/2008US20080312424 rapid and sensitive detection of post-translationally modified proteins; exploits mutant of beta-1,4-galactosyltransferase to selectively transfer unnatural ketone functionality, for attaching biotin; detecting cancer, Alzheimer's disease, neurodegeneration, cardiovascular disease, and diabetes
12/18/2008US20080312423 Preparation of Metal Ion-Lactoferrin
12/18/2008US20080312421 Use of A33 antigens and JAM-it
12/18/2008US20080312418 Antibody Specific for Human 4-1BB Receptor
12/18/2008US20080312417 Ucp5
12/18/2008US20080312415 Long lasting fusion peptide inhibitors for hiv infection
12/18/2008US20080312414 quickly separating lipoproteins other than HDL (High Density Lipoprotein) from a biological fluid; mixing a biological fluid containing the lipoproteins other than HDL with a precipitant, circulating the biological fluid through a carrier used for separating the lipoproteins other than HDL
12/18/2008US20080312413 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
12/18/2008US20080312412 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines
12/18/2008US20080312410 Cysteine-containing peptide tag for site-specific conjugation of proteins
12/18/2008US20080312409 antiapoptosis agents; transduction domains
12/18/2008US20080312294 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4 beta ,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; glucocorticoid receptor modulators; antiinflammatory agents; Alzheimer's disease; side effect reduction
12/18/2008US20080312270 Compounds and methods useful for treating asthma and allergic inflammation
12/18/2008US20080312179 High level expression of recombinant human erythropoietin having a modified 5'-UTR
12/18/2008US20080312178 Human G-Protein Receptor HGBER32
12/18/2008US20080312158 Semaphorin Gene Family
12/18/2008US20080312155 modified metastin containing aza-glycine, methyl arginine and N-acetyl tyrosine amino acids; cancer metastasis suppressing activity, a cancer growth suppressing activity
12/18/2008US20080312154 Administration of adipocytokine and adiponectin for treating headache and methods of diagnosing headache by measuring adiponectin
12/18/2008US20080312152 Glycosylated Probnp
12/18/2008US20080312151 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone
12/18/2008US20080312148 the protein is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b)
12/18/2008US20080312146 METH1 and METH2 Polynucleotides and Polypeptides
12/18/2008US20080312143 Modified Cdna for High Expression Levels of Factor VIII and Its Derivatives